ArticleJournal of pharmacy & bioallied sciences2013
Pathogenesis and therapeutic intervention of oral submucous fibrosis.
Article in Journal of pharmacy & bioallied sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.
- Prosthetic rehabilitation of oral submucous fibrosis patients: A systematic review of published case reports and case series.PloS one · 2017Pooled it
- Efficacy of Emblica Officinalis and Curcumin Longa, Two Significant Herbal Antioxidants, in the Management of OSMF: A Comparative Cross-sectional Study.Journal of pharmacy & bioallied sciences · 2025Article
- Management of oral sub-mucous fibrosis using platelet-rich plasma and triamcinolone with hyaluronidase.Bioinformation · 2025Article
- Efficiency of turmeric, triphala and aloe vera in the treatment of oral submucous fibrosis.Bioinformation · 2025Article
- Cyclooxygenase-2 (COX-2) Expression in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.Journal of pharmacy & bioallied sciences · 2022Article
- Adipose-derived mesenchymal stem cell exosomes inhibit transforming growth factor-β1-induced collagen synthesis in oral mucosal fibroblasts.Experimental and therapeutic medicine · 2021Article
- Article
- Use of Aloe Vera and Turmeric Paste as a Supplementary Medicine in Oral Submucosal Fibrosis: A Pilot Study.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2019Article
- Comparison of Efficacy of Lycopene and Lycopene-Hyaluronidase Combination in the Treatment of Oral Submucous Fibrosis.Journal of pharmacy & bioallied sciences · 2019Article
- Low-power laser irradiation inhibits arecoline-induced fibrosis: an in vitro study.International journal of oral science · 2017Article
- Proposed new grading of oral submucous fibrosis based on cheek flexibility.Journal of clinical and experimental dentistry · 2014Article
- Comparative study of the efficacy of herbal antioxdants oxitard and aloe vera in the treatment of oral submucous fibrosis.Journal of clinical and experimental dentistry · 2014Article
- Spirulina and pentoxyfilline - a novel approach for treatment of oral submucous fibrosis.Journal of clinical and diagnostic research : JCDR · 2013Article
- Comparative evaluation of alteration in taste perception among Gutkha chewers with and without OSMF and healthy subjects: A prospective case-control study.Journal of oral and maxillofacial pathology : JOMFPArticle
- Medical management of oral submucous fibrosis.Asia-Pacific journal of oncology nursingArticle
- Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis.Journal of oral biology and craniofacial researchArticle
- Comparative evaluation of spirulina and lycopene as an adjuvant to intralesional corticosteroid injection therapy in the management of oral submucous fibrosis: A pilot study.National journal of maxillofacial surgeryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral submucous fibrosis (OSF) is a chronic, progressive, potentially malignant condition affecting the oral cavity and frequently involving the upper part of the aerodigestive tract including the oropharynx and the upper part of the esophagus. It is characterized by juxtaepithelial inflammatory reaction and progressive fibrosis of lamina propria, leading to stiffening of the oral mucosa eventually causing trismus. This condition is associated with significant morbidity and high risk of malignancy. Over the years, several drugs and combinations have been tried for the treatment of submucous fibrosis, but with limited success, because of its unclear molecular pathogenesis. Till date, there are no known effective treatments for OSF. The aim of this article is to emphasize on the molecular changes taking place in OSF and possible therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.